Drug Research

Resistance to historically effective antimalarial drugs has contributed to the resurgence of malaria across sub-Saharan Africa in the past decade. The recent discovery of parasitic resistance to Artemisinin monotherapies underscores the urgent need for new and more effective antimalarial treatments.

Medicines for Malaria Venture (MMV) is a non-profit organization created to discover, develop and deliver new antimalarial drugs through effective public-private partnerships. MMV does this by providing drug companies with supplmental funding, technical expertise and logistical support. It currently has over 20 new products in the pipeline.

For more information about Drug Research for malaria control, please visit MMV's website.

Must Read Malaria Keeps Killing Millions May 16, 2008 GlaxoSmithKline and Medicines For Malaria Venture announce new collaboration to investigate novel antimalarial compounds January 28, 2008 Newest Malaria Medicine May Be Losing Potency in Asia, WHO Says October 17, 2007 Certain Combination Therapy Found More Effective For Treating Malaria In African Children May 28, 2007 Scientists discover new compound that kills drug-resistant malaria February 12, 2007	AFM Articles Shelving malaria April 02, 2009 Malaria Drugs Shelf-Life Possibly Much Longer Than Expected February 26, 2009 Malaria Keeps Killing Millions May 16, 2008 Medicine tariffs: how they cost lives August 10, 2006 Remove Medical Tariffs February 27, 2006 » more...	News Experimental Novartis drug shows malaria promise September 02, 2010 Scientists Develop New Drug Treatment for Malaria August 17, 2010 Gates grant funds production of genetically engineered malaria drug July 08, 2010 Merck gives malaria drug to non-profit group March 18, 2009 Sweet pill tackles child malaria October 14, 2008 » more...
Research Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments June 11, 2010 Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial November 17, 2009 The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum March 16, 2009 Manslaughter by Fake Artesunate in Asia - Will Africa Be Next? June 13, 2006	Press Releases DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving Drugs June 24, 2008 Scientists discover new compound that kills drug-resistant malaria February 12, 2007 MissionMore than 4.3 million medicines tested thanks to calculation grids February 08, 2007 Novartis Institute for Tropical Diseases Inaugurates New Indonesian Research Initiative to Study Dengue fever, Tuberculosis and Malaria January 25, 2007	Events No Events found for this issue